| Literature DB >> 36060781 |
Anna Bereznicka1, Krzysztof Mikolajczyk1, Marcin Czerwinski1, Radoslaw Kaczmarek1.
Abstract
Glycosphingolipids (GSLs) are ubiquitous components of the cell membranes, found across several kingdoms of life, from bacteria to mammals, including humans. GSLs are a subclass of major glycolipids occurring in animal lipid membranes in clusters named "lipid rafts." The most crucial functions of GSLs include signal transduction and regulation as well as participation in cell proliferation. Despite the mainstream view that pathogens rely on protein-protein interactions to survive and thrive in their hosts, many also target the host lipids. In particular, multiple pathogens produce adhesion molecules or toxins that bind GSLs. Attachment of pathogens to cell surface receptors is the initial step in infections. Many mammalian pathogens have evolved to recognize GSL-derived receptors. Animal glycosphingolipidomes consist of multiple types of GSLs differing in terminal glycan and ceramide structures in a cell or tissue-specific manner. Interspecies differences in GSLs dictate host specificity as well as cell and tissue tropisms. Evolutionary pressure exerted by pathogens on their hosts drives changes in cell surface glycoconjugates, including GSLs, and has produced a vast number of molecules and interaction mechanisms. Despite that abundance, the role of GSLs as pathogen receptors has been largely overlooked or only cursorily discussed. In this review, we take a closer look at GSLs and their role in the recognition, cellular entry, and toxicity of multiple bacterial, viral and fungal pathogens.Entities:
Keywords: bacteria; blood groups antigens; fungi; glycosphingolipids; viruses
Year: 2022 PMID: 36060781 PMCID: PMC9437549 DOI: 10.3389/fmicb.2022.958653
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Figure 1(A) Schematic representation of a GSL structure. Ceramide moiety comprises sphingoid backbone (based on sphingosine d18:1Δ4) and N-acyl chain. (B) A backbone relational depiction of major GSL synthesis pathways and an overview of glycan root structures. Names and symbols are presented on figure according to IUPAC (Merrill et al., 2007), while monosaccharide symbols are consistent with Varki and Sharon recommendations (Varki et al., 2017); Cer: ceramide.
Figure 2Schematic representation of major glycosphingolipid biosynthesis pathways, highlighting GSLs participating in pathogen binding. Biosynthesis of GSLs proceeds in the endomembrane system, beginning in the endoplasmic reticulum by ceramide synthesis from sphingoid base and acyl-CoA, and continues in the Golgi apparatus. Ceramide may be galactosylated in the ER (producing GalCer) or transported to the cis-Golgi to produce GlcCer and LacCer. LacCer is used for the production of more complex GSLs by specific Golgi-resident glycosyltransferases, creating several GSL series pathways. LacCer is utilized by (1) β1,4-N-acetylgalactosylaminyltransferase (B4GALNT1) initiating the asialo series; (2) β1,3-N-acetylglucosaminyltransferase (B3GNT5), producing Lc3, which is converted to Lc4, the precursor for the lacto and neolacto series GSLs; (3) α1,4-galactosyltransferase (A4GALT), producing Gb3, thus initiating the globo series pathway; (4) α2,3-sialyltransferase (ST3GAL5), producing GM3, which belongs to the ganglio series. The ABO histo-blood group antigens are subsequently formed from the H antigen (it is also the precursor of the Leb antigen, belonging to the Lewis blood group system) by specific GTs; α1,3-N-acetylgalactosyltransferase (A transferase) synthesizes the A antigen, while α1,3-galactosyltransferase (B transferase) synthesizes the B antigen. The Lea and Lex blood group antigens are created by fucosyltransferase 3. More complex glycan structures of ganglio-series GSLs are formed by a sequential action of different GTs, such as N-acetylgalactosaminyltransferases, galactosyltransferases and sialyltransferases, producing the GM2, GM1a and GD1a gangliosides. GM3 may be further processed by α2,8-sialyltransferase 1, forming GD3. GSLs in green play roles in interactions with pathogens. Glycosyltransferases involved in GSL synthesis are shown in red [Figure was created with BioRender.com].
Figure 3Schematic representation of selected GSLs involved in host-pathogen interactions. Fungi, bacteria and viruses may bind various types of GSLs residing in the human membranes. These GSLs belong to different GSL-series, such as asialo, lacto, neolacto, ganglio [Figure was created with BioRender.com].
Summary of described pathogen ligands, host receptors and relevance of these interactions in infectious diseases epidemiology.
| Pathogen | Pathogen ligand (s) | GSLs receptor(s) | Possible implication/Epidemiology | References |
|---|---|---|---|---|
| BACTERIA | ||||
|
| OmpA, Bap, BLP-1 and BLP-2 | GalCer, GlcCer, GgO3, GgO4, Lc3, nLc4, iGb3 |
no binding to glycoconjugates with terminal Galα1 → 4Gal or Galα1 → 3Gal moieties (besides iGb3); resistant to almost all available antimicrobials approximately 1 million cases annually | |
| LPS | GM1, GD1a |
bacteria produce antibodies against host GM1 and GD1a resulting in Guillain-Barré syndrome development. | ||
| Botulinum neurotoxin; | C-type: sialoparagloboside, GM3 and Lc3Cer; |
25% of an average of 110 reported cases of botulism annually in the US are foodborne botulism 500–600 cases annually before a vaccine at present, 8 tetanus toxoid-containing vaccines are administrated. Recommended in a different range of age epidemiologic surveillance efforts have been directed toward mitigating hospital-acquired | ||
| Shiga toxin-producing | Shiga toxins (subunits B); | Gb3 (main receptor), Gb4, Forssman (mostly Stx2e in piglets, also identified in pigeons); sialylα2 → 3lactose, GalNAcβ1 → 4Galβ disaccharide in asialoceramides |
Gb3-depleted cells ( p phenotype individuals resistant to Shiga toxins toxicity; over 63, 000 cases (USA); huge economic losses during outbreaks 11, 000, 000 cases/year in the USA, approximately 150, 000, 000 worldwide. Several factors are related with develop a UTI phenotype: dysfunctions of the urinary tract and/or genetic mechanisms involved in the innate immune response control 220, 000, 000 cases and over 50, 000 deaths annually (in developing countries among children aged <5 years) | |
|
| BabA | Lewis antigens (Leb), LacCer |
individuals are more susceptible to the binding of bacterial adhesin; in the mouse model Leb plays a crucial role in the most common gastrointestinal tract bacterial infection worldwide (it was estimated that half of the human population is infected by | |
|
| LecA | Gb3 |
interaction with hosts receptor as “lipid zipper” Lec-A/Gb3 ligand suppression results in a reduced invasion of | |
|
| Cholera toxin (CT) | GM1 |
cholera affects impoverished populations without proper access to adequate water and sanitation (mostly in Asian countries) The global oral cholera vaccine was created in 2011 for a rapid response to cholera outbreaks and protects against cholera | |
| VIRUSES | ||||
| HCMV | N/A | SGGLs, especially SGLPG |
lactosamine repeats could also play a role in the preferential binding of HCMV; SGLPG had a stronger inhibitory effect; 68.7% among HCMV positive children are aged <6 months, and children aged above 6 months result in 31.3% | |
| HIV | gp120 | Gb3, GM3, GD3 |
soluble Gb3 (adamantylGb3) analogue may bind gp120 and thus inhibit viral infection gp120 binding to GalCer triggers events that allow infecting CD4-negative cells. Modification of the lipid moiety in GalCer affects binding of the virus to CD4 +/− cells with varying degrees of inhibition the inducible modulation of GSL content on the host cell surface, especially under proinflammatory conditions, can have a significant impact on HIV interacts with the host cell (influencing the composition of the plasma membrane from which approximately 37.7 million people living with HIV (data from 2020), over two-thirds of whom (25.4 million) are in the WHO African Region | |
| Human Parvovirus B19 | Interaction with VP1u, but direct ligand unknown | P antigen |
presence of Gb4 on the host cell surface is required, but not sufficient for productive infection most common in school-aged children; transmission of the virus occurs through respiratory secretions and blood products | |
| Noroviruses | VLPs, receptor binding site lies at the outermost end of the P domain of capsid | HBGAS (ABH, Lewis) |
P domain dimer plays a crucial role in the formation of the receptor binding interaction noroviruses can bind to non-HBGAS receptors, e.g.: heparan sulfate, histon 1, or breast milk glycans HMO can inhibit noroviruses infections noroviruses infections are the most common foodborne illnesses (according to CDC) 21 million cases of gastrointestinal illness in the USA each year | |
| Polyomaviruses | BKV and JCV polyomaviruses | NeuAcα2→3Gal and NeuAcα2→6Gal on gangliosides; |
pseudoreceptors are O-l-linked glycoproteins α4β1 integrin may serve as co-receptor virus entering the host cell by clathrin-dependent endocytosis HIV/AIDS patients have been reported more susceptible to polyomaviruses infections | |
| Rotaviruses | VP8 (spike protein) | HBGAS (A, H, Leb) |
RTs infections cause significant economic losses in agriculture over 500,000 deaths in developing countries could possess a frequent cause of childhood morbidity in industrialized countries more than 600,000 young children die from RTS infections approximately 2.4 million children are hospitalized annually from rotavirus disease (mostly in South-East Asia and sub-Saharan Africa) | |
| FUNGI | ||||
| β-(1,3)-glucan, β-(1,6)-side chain branched glucan, fucose-binding lectins | Lactosylceramide, asialo-GM1, Lea, Lex and H-active glycans |
cause candidiasis, including vaginal (only for Le(a-b-) phenotype was connected with recurrent vaginitis in women nonsecretors are more prone to FUT2-null mice showed a threefold increased sensitivity for infections with | ||
|
| Hyaluronic acid (HBMEC cells) | Lactosylceramide |
cause cryptococcosis, 220,000 cases annually worldwide (for people living with HIV/AIDS) liposomes containing LacCer inhibit the binding of this fungi the binding of terminal galactose residue of LacCer is essential for binding and its removal abolishes binding | |
|
| HSP60, β-(1,3)-glucan | Lactosylceramide, GM1 |
caused histoplasmosis, 500,000 cases every year in the U.S. the interaction between GM1 may be a co-receptor in the initial steps of | |
|
| N/A | GalCer, LacCer, CTH, GD3, GD1a GM1, GM3, |
responsible for paracoccidioidomycosis, 15,000 cases detected since 1930, mostly in Brazil GM1 localized in lipid rafts of epithelial cells and lung fibroblasts may serve as receptor for removal of | |
|
| β-(1,3)-glucan | Lactosylceramide |
responsible for pneumonia in immunocompromised patients current global estimates are as high as 500,000 annual cases, with a mortality of 10 to 30% LacCer of host cells involves in binding and internalization of | |
|
| β-(1,3)-glucan | Lactosylceramide |
commensal, although may cause opportunistic infections in patients with chronic disease, cancer, and immunosuppression | |
|
| N/A | Lactosylceramide |
responsible for sporotrichosis in the state of Rio de Janeiro, Brazil, more than 2,200 cases were reported during 1998–2009 another study suggested a rate of 48 to 60 sporotrichosis cases per 100,000 population in the south-central highlands of Peru | |
N/A, no data, HBMEC: Human brain microvascular endothelial cells, HBGASs: Human blood group antigens.
The administration of H-active glycans in the case of C. albicans vaginitis infection, could decrease the sensitivity for this pathogen.
Examined only for P. brasiliensis conidia.